A phase I pharmacokinetic and safety evaluation of oral pazopanib dosing administered as crushed tablet or oral suspension in patients with advanced solid tumors. [electronic resource]
Producer: 20121029Description: 1566-74 p. digitalISSN:- 1573-0646
- Administration, Oral
- Adult
- Aged
- Aged, 80 and over
- Antineoplastic Agents -- administration & dosage
- Demography
- Dose-Response Relationship, Drug
- Female
- Humans
- Indazoles
- Male
- Middle Aged
- Neoplasm Staging
- Neoplasms -- drug therapy
- Pyrimidines -- administration & dosage
- Sulfonamides -- administration & dosage
- Suspensions
- Tablets
- Time Factors
- Treatment Outcome
No physical items for this record
Publication Type: Clinical Trial, Phase I; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.